Home>Topics>Companies>IMS Health

IMS Health RX

  1. All
  2. Commentary
  3. Headlines
    1. FDA Ruling Redefines Testosterone Opportunity; Significantly Lowering Acrux Fair Value Estimate


      Wed, 4 Mar 2015

      evidence based, or off-label, prescribing which has fueled testosterone use over the previous decade, according to IMS Health sales data. The FDA aims to curb overprescribing by doctors, and the associated potential increased risk of heart attacks

    2. Our Take on the Second Quarter


      Mon, 30 Jun 2014

      On the IPO front, the quarter saw the debut of, among others, Ally Financial ALLY, GoPro GPRO, JD.com JD, and IMS Health IMS. The notable S-1 filings in the quarter included Chinese e-commerce giant Alibaba and GoDaddy. Sector-by

    3. Shares of TPG-backed IMS Health rise in debut


      Fri, 4 Apr 2014

      (Reuters) - Shares of TPG Capital Management-backed IMS Health Holdings Inc rose as much as 14 percent in their trading debut, valuing the healthcare information company at up to $7.55 billion.

    4. UPDATE 1- IMS Health IPO at $20/shr, values co at about $6.64 bln


      Thu, 3 Apr 2014

      April 3 (Reuters) - IMS Health Holdings Inc, TPG Capital Management-backed healthcare information company, said its initial public offering was priced at $20 per share, valuing the company at about...

    5. Trouble in Plain Sight


      Mon, 27 Jan 2014

      IMS Health is on the right track for growth.

    6. IMS Health hires JPMorgan to lead IPO -sources


      Tue, 17 Dec 2013

      NEW YORK, Dec 17 (Reuters) - IMS Health Inc has hired JPMorgan Chase & Co Inc to lead a proposed initial public offering that could value the private equity-owned healthcare information company at...

    7. Emerging Nations: A Blossoming Field For Drug and Medical-Device Firms


      Mon, 17 Sep 2012

      heating up in the emerging nations. The emerging nations currently account for 20% of all drug sales, according to IMS Health . And it’s forecast that drug sales there will rise 85% by 2016, to $359 billion from $194 billion in 2011; that

    8. PPD Names New CEO


      Mon, 19 Sep 2011

      Raymond H. Hill joined PPD as chief executive officer and a member of the board last week. He previously was president of IMS Health 's Consulting Group, which is a leading health-care industry consultant. Hill's experience as a consultant in

    9. Drug spending slows: IMS


      Tue, 19 Apr 2011

      NEW YORK (Reuters) - Spending growth on prescription drugs slowed to 2.3 percent in 2010 -- the second lowest level in 55 years, according to a report by IMS Health .

    « Prev12345Next »
    Content Partners